openPR Logo
Press release

Significant CAGR Of 7.8%, Global Market For In Situ Hybridization (ISH) Is Anticipated To Reach $7.8 Billion By 2024 2017

In Situ Hybridization Market

In Situ Hybridization Market

ResearchMoz presents professional and in-depth study of "In Situ Hybridization: Market Shares, Strategy, and Forecasts, Worldwide, 2018 to 2024". This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future.

The 2018 study has 242 pages, 83 tables and figures. Worldwide markets are poised to achieve continuing growth as In Situ Hybridization is used in diagnostic situations to analyze single cells inside tissue. Managing single cell diagnostics in real time, encouraging collaborative business efforts. Lowering transaction management costs is a key benefit.

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
Advances in RNA in situ hybridization transform molecular detection with morphological context enabling new applications. Scientists use RNA ISH to extract data dimensions.

Get a Sample PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1657153

Immunohistochemistry (IHC) and RNA in situ Hybridization are widely used technologies sharing the unique capacity to analyze a marker at the single cell level while preserving the morphological context. In different situations, IHC and ISH are used in conjunction to validate data or provide complementary information.

In situ hybridization (ISH) is a powerful technique for localizing specific nucleic acid targets within fixed tissues and cells, allowing users to obtain temporal and spatial information about gene expression and genetic loci. While the basic workflow of ISH is similar to that of blot hybridizations—the nucleic acid probe is synthesized, labeled, purified, and annealed with the specific target—the difference is the greater amount of information gained by visualizing the results within the tissue.

The global market for In Situ Hybridization (ISH) at $4.3 billion in 2017 is anticipated to reach $7.8 billion by 2024 2017. CAGR of 7.8% in the next five years (2017 to 2024). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are expected to drive the growth of the market in the coming years.

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, electronics.ca, Bloomberg, and Thompson Financial.

WinterGreen Research is positioned to help customers facing challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise. Customers trust wintergreen research to work alongside them to ensure the success of the participation in a particular market segment.

WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.

Companies Profiled

Market Leaders

- Leica Biosystems Nussloch GmbH
- Thermo Fisher Scientific
- F. Hoffmann-La Roche AG
- Abbott Laboratories
- Agilent Technologies
- PerkinElmer
- Qiagen / Exiqon A/S
- Merck KGaA
- BioGenex Laboratories
- BioTechne / Advanced Cell Diagnostics (ACD)

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/in-situ-hybridization-market-shares-strategy-and-forecasts-worldwide-2018-to-2024-report.html/toc

Key Topics

- In Situ Hybridization
- Molecular Diagnostics
- Cervical Cancer Stain
- Fish Steps Reduction
- Fluorescence In Situ Hybridization (FISH)
- In Situ Hybridization (ISH)
- FISH Probe Kit
- Cancer
- Chromosonal Abnormalities
- Infectious Diseases
- Inflammatory Diseases
- Fluorescence In Situ Hybridization (FISH)
- Chromogenic In Situ Hybridization (CISH)
- Human Genetic Tests
- Microbial Tests
- In Vitro Diagnostics
- System for the Analysis of Solid Tumors
- Hybridization Technique
- Detection of Long Non-
- Coding DNA
- Coding RNA

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ https://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Significant CAGR Of 7.8%, Global Market For In Situ Hybridization (ISH) Is Anticipated To Reach $7.8 Billion By 2024 2017 here

News-ID: 1591122 • Views:

More Releases for ISH

In Situ Hybridization (ISH) Market Research Report 2015-2025
About the Global In Situ Hybridization (ISH) Market Research Report 2015-2025: Global In Situ Hybridization (ISH) Market Research Report 2015-2025 is divided into various key segments like device type, material, applications, and end users. The report is thoroughly analyzed and studied by the researchers to offer deep insights on each of these segments with statistics. This information is beneficial for the manufacturers in the industry to plan their policies and strategies
In Situ Hybridization (ISH) Market to Record an Exponential CAGR by 2025
Researchmoz added Most up-to-date research on "In Situ Hybridization (ISH) Market to Record an Exponential CAGR by 2025" to its huge collection of research reports. In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small
Global In-situ Hybridization (ISH) Market Size,Share,Status and Forecast 2017-20 …
ISH is a technique for localizing specific nucleic acid targets within fixed tissues and cells, providing temporal and spatial information about gene expression and genetic loci. While the basic workflow of ISH is similar to that of blot hybridizations, the nucleic acid probe is synthesized, labeled, purified, and annealed with the specific target; the difference is the greater amount of information gained by visualizing the results within the tissue. Get
Ihc And Ish Slide Staining Systems Market Trends and Key Developments
IHC (Immunohistochemistry) and ISH (In situ hybridization) are histopathology diagnostic techniques based on intracellular interactions. IHC and ISH techniques have myriad of applications like disease diagnosis, drug development, karyotyping and others. ISH and IHC techniques have become integral part of the diagnostic histopathology however pcerforming these techniques in the laboratory requires time and possibility for occurrence of errors remains which in turn hamper the results. The staining process involved in
Ish Spencer Becomes Managing Director and Partner at US Capital Partners
Private investment bank promotes senior executive to partnership level, following another year of strong growth at the firm. San Francisco, CA, USA, March 16, 2016 -- US Capital Partners Inc. is pleased to announce the recent appointment of Ish Spencer as Managing Director and Partner at the firm. Headquartered in San Francisco, US Capital Partners is a private investment bank that makes direct debt investments between $500,000 and $100 million, participates
Showcase of World’s first self-powered CO2 Sensor at ISH 2011
EnOcean Alliance member Gas Sending Solutions (GSS) announces first commercially available wireless CO2 sensor for sustainable buildings Cumbernauld, Scotland, 2 March 2011 — Gas Sending Solutions (GSS) will showcase the world’s lowest power CO2 gas sensor enabled by revolutionary EnOcean self-powered wireless technology at ISH 2011 – the leading international trade fair for innovative bathroom design, energy efficient heating and air-conditioning technology and renewable energies – taking place in Frankfurt, 15-19